Orchid Pharma Ltd - ORCHID PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE191A01027
₹ 565.30 (-5.00%) icon11 Aug, 2023, 3:29:37 PM
Open
₹ 599.95
Prev. Close
₹ 595.05
Turnover(lac)
₹ 181.04
Day's High
₹ 599.95
Day's Low
₹ 565.30
52 Wk High
₹ 634.80
52 Wk Low
₹ 296.10
Book Value
₹ 211.79
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 2,867.15
P/E
201.86
EPS
2.80
Div. Yield
0.00

Orchid Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 8/11/2023 3:29:37 PM

    ₹ 565.3 -29.75 -5.00
  • Open
  • ₹ 599.95
  • Prev. Close
  • ₹ 595.05
  • Turnover(Lac.)
  • ₹ 181
  • Day's High
  • ₹ 599.95
  • Day's Low
  • ₹ 565.3
  • 52 Week's High
  • ₹ 634.8
  • 52 Week's Low
  • ₹ 296.1
  • Book Value
  • ₹ 211.79
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 2,867.15
  • P/E
  • 201.86
  • EPS
  • 2.8
  • Divi. Yield
  • 0

Orchid Pharma Ltd Corporate Actions

04 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Aug , 2023

12:00 AM

08 Jul , 2023

12:00 AM

AGM

Announcement date: 08 Jul , 2023

View Details

27 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

02 Dec , 2022

12:00 AM

28 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Nov , 2022

12:00 AM

02 Dec , 2022

12:00 AM

BookCloser

View Details

13 Jul , 2023

12:00 AM

BookCloser

View Details

Orchid Pharma Ltd News and Update

Image not found
  • 11 August, 2023 |
  • 7:25 PM

Recommendation: Buy; Target price: Rs 3150

Article Image
  • IIFL News Service |
  • 11 August, 2023 |
  • 7:25 PM
Image not found
  • IIFL News Service |
  • 11 August, 2023 |
  • 7:25 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Orchid Pharma Ltd SHAREHOLDING SNAPSHOT
14 August , 2023 | 07:35 AM

PROMOTER - TOTAL72.40%

Indian: 72.40%

Foreign: 0%

NON-PROMOTER - TOTAL 27.60%

Institutions: 22.09%

Non-Institutions: 5.51%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Orchid Pharma Ltd FINANCIALS

Orchid Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Orchid Pharma Ltd

  • Tanu Singla
  • Independent Director
  • Dharam Vir
  • Independent Director
  • Mudit Tandon
  • Independent Director
  • Manoj Goyal
  • Independent Director
  • Manish Dhanuka
  • Managing Director
  • Mridul Dhanuka
  • Whole-time Director
  • Ram Gopal Agarwal
  • Chairman (Non-Executive)
  • Marina Peter
  • Company Sec. & Compli. Officer

Summary

Orchid Pharma Ltd., is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries. Orchids world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India. The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company is a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery, which was incorporated on 1st July 1992 as a 100% Export Oriented Unit (EOU). Orchid has two manufacturing sites for APIs (at Alathur near Chennai and at Aurangabad, near Mumbai) and three manufacturing sites for Dosage forms (at Irungattukottai and Alathur in Chennai), besides two R&D centres (at Sholinganallur and Irungattukottai, Chennai), all are state-of-the-art and have several international regulatory approvals, including the US FDA and UK MHRA. Orchids API facilities are ISO certified for their quality, environmental management and operational health and safety systems. Orchid has a Joint Venture in China for manufacturing sterile APIs. The Company commenced its operation in the year 1994, also in the same... Read More


Reports by Orchid Pharma Ltd


Reports by Orchid Pharma Ltd

Company FAQ

No Record Found